PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries
Open Access
- 31 August 2023
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 103, adv6532
Abstract
Enhanced treatment options for psoriasis and growing use of guidelines increased the potential to better quality of psoriasis care in Europe. The aim of the PsoBarrier EU study is to compare the quality and processes of psoriasis care in four European countries with different healthcare systems, based on validated quality indicators. This cross-sectional survey was conducted in dermatology centres in Denmark, Germany, Poland and Spain on 1,304 patients, using standardized patient and physician questionnaires. Measured by quality of psoriasis care indicators, patients in Poland had the most critical outcomes, such as the highest disease severity (Psoriasis Area and Severity Index; PASI) and lowest health-related quality of life (Dermatology Life Quality Index; DLQI). This indicates differences in psoriasis care, with Polish participants experiencing more severe psoriasis and its consequences. Differences in the healthcare systems, which create barriers to accessing treatments, could explain variations in quality of care.Keywords
This publication has 24 references indexed in Scilit:
- Psoriasis and suicidality: A systematic review and meta-analysisJournal of the American Academy of Dermatology, 2017
- Cost‐of‐illness of psoriasis – results of a German cross‐sectional studyJournal of the European Academy of Dermatology and Venereology, 2017
- The German National Program on Psoriasis Health Care 2005–2015: results and experiencesArchives of Dermatological Research, 2016
- Psoriasis Causes Significant Economic Burden to PatientsDermatology and Therapy, 2014
- Quality of life in psoriasis patientsExpert Review of Pharmacoeconomics & Outcomes Research, 2014
- Demographic characteristics and health-related quality of life of patients with moderate-to-severe psoriasis: The VACAP studyActas Dermo-Sifiliograficas, 2013
- Evaluation of Quality of Care and Guideline-Compliant Treatment in PsoriasisDermatology, 2009
- Quality of Life in Patients with Psoriasis: A Systematic Literature ReviewJournal of Investigative Dermatology Symposium Proceedings, 2004
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978